跳至主要内容
临床试验/NCT02488291
NCT02488291已完成不适用

Effect of 0.5µg/ml Sufentanil and Ropivacaine Towards Pregnant Women and Fetus in Analgesia Labor

Fudan University0 个研究点目标入组 120 人开始时间: 2014年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
120
主要终点
VAS(visual analog pain score)

研究概览

简要总结

The investigators study the efficacy of epidural sufentanil/ropivacaine for analgesia labor in primiparas so as to decrease perinatal complications of analgesia labor.

详细描述

A prospective study of 120 full-term parturients receiving labor analgesia were randomly assigned into 2 groups: the 0.5Sufen group (N=60), the 0.25Sufen group (N=60).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
25 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients had regular prenatal examinations at the outpatient clinic;
  • They were between 25 to 35 years of age)
  • They had a gestational age ≥37 weeks and < 42 weeks;
  • They had an estimated fetal weight ≥ 2,500 g and < 4,200 g.

排除标准

  • a history of spinal surgery,
  • platelet count <100×109 /L ,
  • coagulation disorder,
  • sensorimotor disorder of lower extremity,
  • leg pain,
  • puncture point infection,
  • heart disease history,
  • pulmonary disease,
  • liver and renal function disorder and
  • a history of neuropsychiatry drugs.

研究组 & 干预措施

0.5 sufentanil

Experimental

0.5µg/ml sufentanil, 0.1% ropivacaine for 6ml/h

干预措施: 0.5µg/ml sufentanil (Drug)

0.5 sufentanil

Experimental

0.5µg/ml sufentanil, 0.1% ropivacaine for 6ml/h

干预措施: 0.1% ropivacaine (Drug)

0.25 sufentanil

Experimental

0.25µg/ml sufentanil, 0.1% ropivacaine for 6ml/h

干预措施: 0.25 sufentanil (Drug)

0.25 sufentanil

Experimental

0.25µg/ml sufentanil, 0.1% ropivacaine for 6ml/h

干预措施: 0.1% ropivacaine (Drug)

结局指标

主要结局

VAS(visual analog pain score)

时间窗: 1 year

comparison with two groups

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zeyong Yang

Hospital

Fudan University

相似试验